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Tularaemia is a zoonotic disease caused by the bacterium Francisella tularensis, which 
may infect  a wide  range of hosts.  The subspecies known to cause disease in Europe is  
F. tularensis subsp. holarctica. The susceptibility to develop disease varies between 
animal species. For example, mountain hares (Lepus timidus) and many small rodent 
species succumb to fulminate disease, while many carnivores and omnivores show no 
signs of clinical disease. 
This thesis has investigated the pathology and serology of tularemia in selected 
wildlife hosts. It has also reviewed the status of tularaemia in Europe in a One-Health 
perspective. 
Tularaemia is widely distributed throughout Europe. Differences in surveillance and 
reporting between countries, different ecosystems, the presence of different species of 
arthropod vectors and wildlife species, present difficulties in making direct comparisons 
across all of Europe. 
The pathology of tularaemia in European brown hares (Lepus europaeus), mountain 
hares and two yellow-necked mice (Apodemus flavicollis) were similar, all presenting 
with acute disseminated disease. However, some of the European brown hares, in 
addition to the acute lesions, also had subacute or chronic changes. This raises the 
question of whether European brown hares in Sweden might play an epidemiological 
role as reservoir of F. tularensis. F. tularensis was also demonstrated in muscles of 
infected hares, which highlights the risk of acquiring infection through consumption of 
under-cooked meat. 
Many predators and omnivores develop antibodies upon infection and therefore may 
be suitable sentinels of the presence of tularaemia. The study revealed seropositivity in 
brown bear, red fox, wild boar and wolverine, for the first time reported in Sweden. 
This thesis contributes to the knowledge of tularaemia in Europe, its pathology in 
European brown hares and yellow-necked mice, and its possible routes of infection and 
shedding. Additionally, it contributes to the understanding of the role of predators and 
scavengers. The results of our studies highlight the importance of further investigations 
of different wildlife species to explore their role in the epidemiology of tularaemia, as 
possible sources of infection, transmitters of disease and potential reservoirs. 
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tularaemia, yellow-necked mouse, wildlife. 
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Tularaemia in Swedish wildlife – a One Health perspective 
Abstract 
  
Tularaemia (harpest) orsakas av bakterien Francisella tularensis och är en zoonos som 
kan   infektera  ett stort antal värdar.  Det subspecies  som orsakar sjukdom  i Europa  är  
F. tularensis subsp. holarctica. Känsligheten för att insjukna varierar mellan djurslag.  
Skogshare (Lepus timidus) och många smågnagararter är exempel på djurarter med hög 
känslighet och dessa dör ofta snabbt i akut sjukdom. Många karnivorer och omnivorer 
visar inga sjukdomstecken efter infektion.  
I denna avhandling har patologiska och serologiska undersökningar utförts på några 
vilda djurarter. En översikt av kunskapsläget om tularemi hos människa, djur och 
vektorer i Europa har sammanställts ur ett One Health-perspektiv. 
Tularemi finns i majoriteten av Europas länder, men variationer i sjukdoms-
övervakning och rapportering, ekosystem, vilda djurarter och arthropoda vektorer gör det 
svårt att göra direkta jämförelser mellan länderna. 
Patologin var likartad hos fälthare (Lepus europaeus), skogshare och två större 
skogsmöss (Apodemus flavicollis). De hade alla akut harpest involverande många organ. 
Några av fälthararna hade, förutom akuta, även subakuta eller kroniska förändringar. 
Detta väcker frågan huruvida fälthare i Sverige kan vara potentiell reservoar för F. 
tularensis. F. tularensis kunde även påvisas i muskulaturen hos infekterade harar, 
medförande en risk för infektion vid konsumtion av otillräckligt tillagat harkött. 
Många rovdjur bildar antikroppar vid infektion, vilket kan göra dem lämpliga som 
biologiska indikatorer för förekomsten av tularemi i ett område. Blodprover som togs i 
fält och förvarades och transporterades under bristfälliga förhållanden var ofta av dålig 
kvalitet, vilket försvårade de serologiska undersökningarna. I studien påvisades 
antikroppar hos brunbjörn, järv, vildsvin och rödräv. Det är första gången antikroppar 
mot F. tularensis påvisas hos dessa djurarter i Sverige. 
Denna avhandling bidrar med kunskap om tularemi i Europa, sjukdomens patologi hos 
fältharar, skogsharar och större skogsmöss, samt möjliga infektions- och utsöndrings-
vägar. Därtill bidrar arbetet till förståelsen av den roll rovdjur och asätare kan spela. 
Resultatet av våra studier visar vikten av att fortsätta studera vilda djurslag för att utröna 
deras roll i tularemins epidemiologi, och huruvida de kan utgöra potentiella 
infektionskällor, smittspridare och reservoarer. 
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1.1 General background 
Tularaemia is an important zoonotic disease caused by Francisella tularensis, a 
small gram negative and facultative intracellular bacterium. F. tularensis subsp. 
tularensis and subsp. holarctica are the subspecies causing significant disease in 
humans and other animals. This zoonotic disease can infect over 300 species, 
including mammals, birds, amphibians and invertebrates (Morner and Addison, 
2001). The concept “one health” recognizes that the health of people is 
connected to the health of animals and the environment, and this is to a high 
degree true for tularaemia. 
F. tularensis subsp. holarctica is found all over the Northern hemisphere, and 
F. tularensis subsp. tularensis historically has been found only in North America 
(Ellis et al., 2002). However, recently F. tularensis subsp. tularensis has been 
found in the environment and in arthropods in Slovakia and Austria (Chaudhuri 
et al., 2007), and in Australia, F. tularensis subsp. holarctica has been detected 
in ringtail possums (Pseudocheirus peregrinus), and in a woman bitten by a wild 
ringtail possum (Eden et al., 2017; Jackson et al., 2012). Symptoms of 
tularaemia are related to the site of entry of the bacteria, the virulence of the F. 
tularensis strain, and the immune status of the host (Anda et al. 2007). 
There are   two  subspecies  responsible for  disease in  humans  and animals,  
F. tularensis subsp. tularensis (type A) and holarctica (type B). The infective 
dose varies between animal species depending on their natural sensitivity and 
the route of infection, in humans the infective dose can be as low as ten bacteria. 
(Sjostedt, 2007).   Type A is considered to be the more  virulent  subspecies  of  
F. tularensis. However, investigations have shown that the virulence also differs 
between subpopulations within type A (Petersen and Molins, 2010). In a study 
in mice, comparing two type B strains and four type A strains, all type A strains 
1 Introduction 
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were more virulent than the type B strains (Molins et al., 2014). The 
phylogeography of F. tularensis type B has been extensively studied (Afset et 
al., 2015; Gyuranecz et al., 2012; Karlsson et al., 2013; Pilo et al., 2009; 
Sissonen et al., 2015; Vogler et al., 2009). Investigations regarding differences 
in the virulence between type B strains are fewer. One interesting finding is the 
difference in presentation of the disease in European brown hare when 
comparing F. tularensis type B genotypes B.12 and B.FTNF002-0. Subacute or 
chronic lesions were associated with B.12 and acute lesions with B.FTNF002-
00. (Gyuranecz et al., 2012; Kreizinger et al., 2017; Origgi and Pilo, 2016). 
Experimental infection of laboratory rats has confirmed a difference in virulence 
between the genotypes, B.FTNF002-00 being the more virulent one (Kreizinger 
et al., 2017). 
1.1.1 Clinical presentations of tularaemia 
In humans, tularaemia has several clinical presentations, including 
ulceroglandular, glandular, oculoglandular, oropharyngeal, respiratory, and 
typhoidal. The type of disease is dependent on the route of infection. In the 
ulceroglandular form, a local skin lesion is often considered to be the route of 
entrance (scratch, cut, insect bite) and the disease progresses to the swelling of 
the regional lymph node, which may ulcerate and suppurate. The glandular form 
of this disease is similar to the ulceroglandular form, but no primary skin lesion 
is detected in these cases. The respiratory form results from inhalation of the 
bacterium and affects the lungs. The oropharyngeal form of tularaemia is linked 
to ingestion of contaminated food or water. A more infrequent clinical 
presentation is typhoidal tularaemia where no route of infection is possible to 
establish.  (Anda et al., 2007). The more virulent type A may cause fulminant 
fatal disease. Generally, type A may cause death in 5-15% of diseased humans 
if left untreated. The more severe forms, often respiratory, caused death in 30-
60% of diseased humans before antibiotic treatment was available. Nowadays 
the fatality rate is 2%. (Dennis et al., 2001). If septicaemia develops it is 
frequently very severe and may lead to septic shock. (Anda et al. 2007). Type B 
is less virulent and causes less severe disease, and is seldom fatal.  
In  animals,  less  is  known  about  the  presentation  of  disease  caused  by  
F. tularensis type B, and most information derives from experimental studies. In 
one study of experimental infection of mountain hares (Lepus timidus), the only 
clinical signs were slight depression (Mörner 1988), but in another study the 
hares were apathic and showed inappetence, polydipsia and ataxia (Borg et al., 
1969). Signs in common hamsters (Cricetus cricetus) ranged from apathy to 
moribund (Gyuranecz et al., 2010a), and in a study of field voles (Microtus 
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agrestis) and bank voles (Myodes glareolus) general malaise was observed 
(Rossow et al., 2014). The clinical symptoms described in a case report of a dog 
were lethargy, in-appetence and fever (Nordstoga et al., 2014). 
1.1.2 Francisella tularensis as a bioterrorist agent 
Due to the low infection dose and its potential to cause severe disease and 
death if not treated, F. tularensis is a potential biological weapon. One important 
characteristic for this purpose is that the bacteria can be made airborne, and the 
infectious aerosol would cause severe respiratory disease in humans. Aerosols 
could also  cause infection  through  the eye,  broken skin or oropharynx.  Since  
F. tularensis is ubiquitous in the nature it is possible to isolate and multiply the 
bacteria under laboratory conditions. (CDC, 2015 and Dennis et al., 2001).  
1.1.3 Differences in susceptibility to develop tularaemia 
The susceptibility to develop disease, and the severity of disease, varies 
between animal species and species are divided into sensitive (class 1), 
intermediate (class 2) and resistant (class 3). In class 1, several small rodent 
species are found (e.g. Microtus spp. and Apodemus spp), while rats (Rattus spp.) 
are confined to class 2. Many lagomorphs belong to class 1, and insectivores can 
be found in class 1 and 2. Carnivores, like the genera Canis, Felis, Vulpes, 
Nyctereutes and Mustela, are classified into class 3, as suggested by Olsufjev 
and Dunayeva (Olsufjev 1970 see Sjöstedt 2007). The European beaver (Castor 
fiber) is placed in class 3, while the American beaver (Castor canadensis) is 
more sensitive and belongs to class 2. (Sjostedt, 2007).  
1.1.4 Tularaemia – an endemic disease with outbreaks 
Tularaemia is endemic in many areas, and outbreaks occur with variable time 
intervals. In highly endemic areas, or natural foci of tularaemia, disease is often 
yearly recurrent and cases appear in higher numbers than in the less affected 
endemic areas. In Sweden, tularaemia currently occurs in areas that previously 
had not shown evidence of presence of the infection. (Petersen and Schriefer, 
2005; Tarnvik et al., 1996). The European Centre for Disease Prevention and 
Control (ECDC) reports that confirmed human cases in EU/EFTA countries 
increased by 70% in 2014 compared to 2013. Sweden was the country that 
reported the highest number of cases (150) (ECDC 2016). Tularaemia outbreaks 
occur regularly in Sweden, the more recent ones in 2010, 2012 and 2015. During 
the outbreak in autumn 2015 859 human cases, 582 of these from the counties 
Norrbotten and Västerbotten, were reported to the Public Health Agency of 
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Sweden (Folkhälsoinstitutet). This is the highest number reported since the 
1960´s. In 35 of 434 confirmed cases (7%), contact with animals was reported 
as the cause. (The Public Health Agency of Sweden, 2017).  During the outbreak, 
the National Veterinary Institute (SVA) received reports of more than 150 dead 
mountain hares in the outbreak area. Thirty-one hares were submitted to SVA 
for necropsy, and tularaemia was confirmed in 24 of these. (Unpublished data). 
During outbreaks, and to a lesser extent also in the years between outbreaks, 
reports of disease in humans and hares are common. The surveillance system is 
passive, and diseased humans and hares are relatively easy to detect, but 
presumably also other wildlife species, e.g. small rodent species, succumb to 
tularaemia unnoticed by surveillance. There is a lack of knowledge about the 
potential effect of tularaemia on wildlife populations in Sweden. During and 
after the outbreaks, the public often reports a decline of the hare population in 
the affected area. The year after a large outbreak in humans and hares 1966-67, 
the mountain hare population in some areas declined to 1/5-1/10 of the 
population before the outbreak (Borg et al., 1969).  
1.2 History 
In 1911, McCoy described a disease in ground squirrels in Tulare County in 
California in the USA, during an investigation of plague in squirrels. The 
squirrels had changes similar to plague, but the plague bacteria could not be 
detected. In 1912, McCoy and Chapin isolated the bacterium behind the disease, 
naming it Bacterium tularense. It was later re-named Francisella tularensis. 
During the following years, tularaemia was linked to deer-fly fever in humans, 
wild hares and rabbits in North America. In the United States, Scandinavia and 
Russia, the existence of the disease in 18th and 19th century was discovered 
retrospectively by medical historians (Francis, 1919 and Olsen, 1975). In Europe 
and Russia, disease outbreaks in humans were associated with high abundance 
of rodents as early as in the16th century. Jacob Ziegler already in 1532 described 
that lemmings died in an epidemic disease in Norway, and also transferred the 
disease to humans. In 1653, Olaus Wormius, described humans with a disease 
causing swelling of glands, and he connected this to the Norwegian´s fear of 
lemming invasion. In the later years of the 19th century the disease was called 
lemming fever. (Pearson, 1998). Extensive work on tularaemia in a large number 
of animal species was performed during the mid-20th century, and a few 
examples are mentioned below. Jellison described tularaemia in North America 
including the geographical distribution, investigating and discussing the role of 
lagomorphs, rodents, insectivores, carnivores, mustelids, non-human primates, 
birds and sheep (Jellison, 1974). In the former Soviet Union, Olsufjev, among 
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others, investigated and reviewed tularaemia in many wild and domestic animal 
species including lagomorphs, rodents, insectivores, herbivores, omnivores, 
carnivores, birds and amphibians, performing bacterial culture, necropsies, 
parasitology and serology. The studies were of both field and experimental type 
(Olsufjev, 1963). These studies contributed with abundant information on the 
vast number of animal species that can be infected and their differences in 
susceptibility to develop disease. During the 1980´s, Pfahler-Jung reviewed the 
global distribution of tularaemia including where the disease was endemic or 
sporadic. Extensive information regarding wildlife species involved in different 
countries, and the importance of ecosystems including vectors was also reviewed 
(Pfahler-Jung, 1989). 
 
In Sweden, the first confirmed cases of tularaemia were reported in a 
mountain hare and three humans who had been in contact with the infected hare 
(Granström, 1931). The number of diagnosed human cases increased the 
following years and in 1938 an outbreak in the north of Sweden was linked to 
abundance of lemmings (Lemmus lemmus). Tularaemia was diagnosed in the 
lemmings, and it was assumed that humans were infected by mosquitoes 
transferring F. tularensis from the rodents rather than by direct contact with the 
lemmings. (Olin, 1942). During the following two decades, several more 
outbreaks occurred with tularaemia reported in humans, hares, squirrels, 
lemmings and voles. In a large outbreak in 1966-1967 involving humans, hares 
and voles, F. tularensis was isolated from 18 of 49 investigated voles, and in a 
study of several small rodent species in Fennoscandia in the early 1970s 
antibodies were detected in some of them (Borg et al., 1969; Omland et al., 
1977). During the outbreak in 1966-1967, the mountain hare population was 
reduced (Borg et al., 1969). Pathological examination of naturally and 
experimentally infected mountain hares showed an acute disease quickly leading 
to death (Borg et al., 1969). Acute disease has also been described in naturally 
infected mountain hares during the 1980s and later on in Sweden and Norway 
(Morner et al., 1988; Vikoren and Djonne, 2008; Vikoren et al., 2008). Serology 
has been performed in cattle (Bos sp), moose (Alces alces), European beaver and 
mountain hare in Sweden. Approximately 50% of the beavers had positive 
antibody titers, but a few cases were also found serologically positive in cattle, 
moose and mountain hares. (Morner and Sandstedt, 1983). 
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1.3 Life cycles, transmission and reservoirs 
1.3.1 Life cycles 
Two principal life cycles of tularaemia are recognized, one terrestrial and one 
aquatic. Previously, F. tularensis subsp. tularensis (type A) was associated with 
the terrestrial, and F. tularensis subsp. holarctica (type B) with the aquatic, but 
nowadays both life cycles are suspected to be present in association with type B 
tularaemia in Europe. The terrestrial cycle is common in central and southern 
Europe, while the aquatic predominates in northern Europe. The terrestrial cycle 
involves the terrestrial environment. Lagomorphs (rabbits and hares) and rodents 
are vertebrate hosts, and ticks are invertebrate hosts and vectors which are 
sources of infection for other hosts. In the aquatic cycle, centred around lakes, 
rivers and water wells, the vertebrate hosts involved are rodent species such as 
voles, muskrats and beavers, and mosquitos act as invertebrate hosts and vectors. 
(Carvalho et al., 2014; Maurin and Gyuranecz, 2016). 
1.3.2 Reservoirs and transmission 
The epidemiology of tularaemia is complex and involves mammals, birds, 
invertebrates such as mosquitos and ticks, and the environment. There is 
insufficient knowledge regarding the disease epidemiology and the interplay 
between the multiple hosts and environmental factors involved. Species that act 
as reservoirs for F. tularensis and their role are incompletely understood. 
Haydon et al. defined reservoirs as “populations or environments where a 
pathogen is permanently maintained and from which the pathogen is transmitted 
to a target population” (Haydon et al., 2002).  
The European brown hare (Lepus europaeus) is considered a reservoir 
species of tularaemia in central and eastern Europe (Gyuranecz et al., 2010b; 
Maurin and Gyuranecz, 2016). These hares show subacute and chronic lesions 
(Gyuranecz et al., 2010b; Sterba and Krul, 1985). In other parts of Europe, for 
example in France and Sweden, the role of the European brown hare as possible 
reservoir of tularaemia is less clear, since the hares mostly present acute forms 
of disease (Decors et al., 2011; Hestvik et al., 2017), thus limiting the time of 
bacterial shedding. Also, these acute septicaemic presentations appear to be fatal 
in the hares so that hares are not able to maintain the infection for prolonged 
periods to act as reservoirs.  Full understanding of possible different disease 
patterns in European brown hares has not been achieved. For example, in 
European brown hares necropsied in Sweden it was observed that a few of the 
hares that died of acute tularaemia also had chronic tularaemic lesions in the 
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lung and/or kidney, probably these hares had a chronic disease that was 
reactivated and caused their death. (Hestvik et al., 2017 and unpublished data 
SVA). These findings warrant further investigations to elucidate if the European 
brown hare also might be a reservoir species in Sweden. Rodent species differ 
in their susceptibility to develop disease, for example species of Apodemus are 
very susceptible, while Rattus spp. have an intermediate degree of susceptibility. 
Therefore, some rodent species might function as reservoirs while others might 
not.  
Tick and mosquito bites, ingestion of contaminated water and direct contact 
with infected animals are important sources of infection. (Maurin and 
Gyuranecz, 2016). F. tularensis have been found in ticks in several European 
countries (Hestvik et al., 2014; Morner et al., 1988), and there is evidence of the 
presence and replication of the bacterium in the midgut and salivary glands of 
the ticks, and also of transstadial transmission. Ticks can transmit bacteria during 
a blood meal and through interrupted feeding. (Petersen et al., 2009; Reif et al., 
2011). Transmission via mosquitos has been less well investigated, but in a 
Swedish study the bacterium was detected in several mosquito species 
(Lundstrom et al., 2011). Experimental studies have shown that mosquitos may 
aquire infection when feeding on infected mammals, but transmission in the 
opposite direction has not been experimentally proven (Thelaus et al., 2014; 
Triebenbach et al., 2010). Some studies have found evidence of transstadial 
transmission (Backman et al., 2015; Thelaus et al., 2014). In a recent study, 
bacteria have been shown to be transferred between mosquitos when feeding on 
flower nectar (Kenney et al., 2017). Since mosquitos have a strong connection 
to water sources, an association between F. tularensis, mosquitos and natural 
waters is stipulated. Investigations of water samples from natural waters in 
endemic areas have detected DNA from F. tularensis subsp. holarctica, and in 
experimental studies the bacterium has been able to survive in water for several 
months (Broman et al., 2011; Forsman et al., 2000). Free-living amoebas can 
interact with different bacteria, and in experimental studies of Acanthamoeba 
castellanii co-cultured with F. tularensis, bacteria were found intracellularly in 
the amoebas. It has also been shown that the bacteria can survive inside the 
amoebas for at least three weeks. It is speculated that amoebas could be 
environmental reservoirs for F. tularensis (Abd et al., 2003; El-Etr et al., 2009).  
Chronically infected animals, as well as acutely infected animals, before they 
succumb to disease, may contaminate the environment with infected urine and 
faeces if the bacterial load is sufficiently high (Bell and Stewart, 1975; 
Gyuranecz et al., 2010b). Carcasses of infected animals may contaminate both 
the terrestrial environment and water sources, and may also be a source of 
infection for predator and scavenger species. Ticks have been postulated as 
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reservoirs of tularaemia. F. tularensis subsp. holarctica was found to persist in 
ticks in an endemic area in Slovakia for six years (Gurycova et al., 1995). The 
finding of F. tularensis DNA in natural waters, and the survival of the bacterium 
in water experimentally may also be a sign that natural waters might be 
environmental reservoirs (Broman et al., 2011; Forsman et al., 2000).  
The information regarding wildlife as reservoirs in Sweden is scant, hares 
and small rodents may play a reservoir role, but this must be further explored.  
1.4 Pathogenesis and immunity 
At the site of infection, F. tularensis invades the host cells, most commonly 
macrophages. F. tularensis has a particular predilection for macrophages, even 
though it can also infect other cell types. (Oyston, 2008). F. tularensis avoid the 
host´s immune system by blocking or weakening signalling in macrophages and 
other immune cells when interacting with the cells´ receptors (Bosio, 2011). To 
gain entry into the macrophage, F. tularensis interacts with several cell surface 
molecules resulting in phagocytosis. Inside the cell cytoplasm the engulfed 
bacteria are taken up by phagosomes. (Barel and Charbit, 2013; Clemens and 
Horwitz, 2007). The membrane of the phagosome is degraded and bacteria are 
free to replicate into high numbers in the cytoplasm of the cell. When the bacteria 
are free in the cytoplasm, they are vulnerable to the cell´s defence mechanisms, 
such as reactive oxygen and nitrogen. F. tularensis has the ability to inhibit or 
interfere with these mechanisms, promoting its own survival in the cytosol. 
(Barel and Charbit, 2013; Bosio, 2011). F. tularensis may induce cell death by 
several pathways. Apoptosis-induced cell death is achieved by induction of 
caspases without an inflammatory response. In pyroptosis, a process induced by 
other types of caspases than in apoptosis, pro-inflammatory cytokines are 
released, inducing an inflammatory response. The signalling complex that 
activates caspases in pyroptosis are called inflammasomes, and they have proved 
to be crucial for host defence against F. tularensis. (Barel and Charbit, 2013; 
Parmely et al., 2009). Unlike other intracytoplasmic pathogens, F. tularensis re-
enter membrane-bound compartments after replication, and this may induce 
autophagocytosis, a process where the cell eats its own content, which may 
trigger cell death (Barel and Charbit, 2013). Pathogen-induced cell death can 
result in the elimination of infected cells and thereby halt the infection, but on 
the other hand it can also be advantageous to the bacteria since immune cells are 
eliminated, thereby suppressing the immune response. By activating the 
different host cell death pathways, bacteria are released and can spread further 
in the body. (Barel and Charbit, 2013; Parmely et al., 2009). 
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The normal incubation period of tularaemia in humans is 3-5 days, but spans 
between 1 and 21 days (Anda, 2007). It is difficult to know the incubation time 
in wild animals, but experimental studies in mountain hares (Borg et al., 1969), 
common hamsters (Gyuranecz et al., 2010a), and field and bank voles (Rossow 
et al., 2014) indicate similar incubation times as in humans. Observable 
symptoms appeared within 2-8 hours in the mountain hares, on day 7 and 8 in 
the hamsters, and days 6-9 in the voles. In a Norwegian study, a dog showed 
symptoms two days after killing an infected hare (Nordstoga et al., 2014).  
The first line of defence is provided by the innate immune response where 
macrophages, dendritic cells, granulocytes, mast cells and natural killing cells 
are activated. Various cytokines are produced that activate humoral and cell-
mediated responses. Around 6-10 days after infection, IgM, IgG and IgA serum 
antibodies are detected, and they reach their highest level approximately one to 
two months after infection. The antibodies persist for about a decade. (Cowley 
and Elkins, 2011). In contrast to humoral immunity, cell-mediated immunity 
may persist for 25 years. (Ericsson et al., 1994). Compared to cell-mediated 
immunity, humoral immunity is often of less importance for protection against 
intracellular  bacteria,   but  since  studies  have  shown   that   a  large  part  of  
F. tularensis bacteria are located extracellularly in the blood, humoral immunity 
might contribute more than previously assumed. (Cowley and Elkins, 2011; 
Forestal et al., 2007). 
1.5 Pathology of F. tularensis subsp. holarctica – a brief 
overview 
In humans, the lesions of tularaemia are often focal. Macroscopically in 
ulceroglandular tularaemia the skin lesions range from erythematous to 
ulcerative at the site of bacterial entrance and enlargement of draining lymph 
nodes, followed by suppurative lymphadenitis (Syrjälä et al., 1984, and Anda, 
2007).  Histopathology reveals that the skin ulcerates and there is infiltration of 
lymphocytes, plasma cells, macrophages and neutrophils, and formation of 
granulomas. The lymph nodes may present with sinus histiocytosis and follicular 
hyperplasia, small abscesses, granulomas and/or casseous necrosis (Asano, 
2012; Syrjala et al., 1984). In oropharyngeal tularaemia, the disease 
macroscopically presents as an ulcerative-exudative stomatitis and pharyngitis, 
and tonsillitis may be present. (Anda, 2007). Histopathological investigations 
show variably appearing morphological changes, such as suppurative 
inflammation, granulomatous inflammation, or extensive areas of necrosis that 
resemble casseous necrosis (Turhan et al., 2013). Pulmonary lesions have been 
less well investigated histologically and is described from diagnostic imaging as 
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pulmonary consolidation and enlargement of hilar lymph nodes (Anda, 2007). 
In one case in the USA where the subspecies of F. tularensis could not be 
determined, histopathology showed multiple necrotic foci and mixed 
inflammatory infiltrate with a large number of macrophages, lymphocytes and 
neutrophils. In the pleura there was chronic inflammation, granulation tissue and 
fibrosis. (Navarro et al., 2011). 
The pathology in animals is dependent on the susceptibility of each respective 
species to develop disease. In wildlife species that are prone to develop acute 
disease, frequently observed gross changes are enlarged spleen, and pinpoint 
necrotic lesions in the spleen, liver and bone marrow. Often, gross lesions are 
inapparent. At histopathological examination, abundant coagulative or lytic 
necrosis with no or minimal inflammation is frequently seen; lesions are often 
described in additional organs and sepsis is apparent (Borg et al., 1969; Hestvik 
et al., 2017; Morner et al., 1988; Rossow et al., 2014; Vikoren and Djonne, 
2008). Acute lesions are often observed in several small rodents, mountain hares 
and European brown hares. In the European brown hare, subacute and chronic 
lesions have also been described (Gyuranecz et al., 2010b; Origgi and Pilo, 
2016), constituting grossly visible inflammatory changes, most frequently in the 
lungs, pericardium and kidneys.  Histopathology shows a predominance of 
granulomatous inflammation. Domestic animals have rarely been investigated 
using pathology, most reports are limited to clinical examinations. One diseased 
dog developed enlargement of pharyngeal, prescapular and popliteal lymph 
nodes after killing a tularaemic hare (Nordstoga et al., 2014). No reports on the 
pathology of cats infected with F. tularensis subsp. holarctica could be found. 
1.6 Diagnosis 
There are several methods that can be used to diagnose an infection by F. 
tularensis, only a few will be mentioned here. 
In humans, and wild and domestic animals, the same methods may be 
applied. Serology is used to detect antibodies in the blood. Commonly used 
serological methods are microagglutination, tube agglutination and enzyme-
linked immunosorbent assay (ELISA). If possible, paired samples are used to 
detect a rise in antibody-titres, ensuring that the infection is ongoing.   
Polymerase chain reaction (PCR) is used on samples from wounds, biopsies 
from lymph nodes or other organs, bronchiolar lavage or blood, to detect the 
bacteria. A less often used method nowadays is to culture for F. tularensis. (The 
Public Health Agency of Sweden, 2007 and Tärnvik, 2007). 
In wildlife, serology is used both in active surveillance of hunted, often 
apparently healthy, animals and in animals found dead. In animals that are 
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diseased and found dead, or euthanized due to disease, necropsy and 
histopathological investigations can be performed. In these cases, common 
diagnostic methods are PCR and immunohistochemistry (IHC) on tissue samples 
to detect the bacteria.  
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The main aim of this thesis was to acquire knowledge of Francisella tularensis 
subsp. holarctica infection in a one health perspective, mainly focusing on the 
disease in Swedish wildlife.  
 
 
More specific aims were: 
 
➢ To review recent information on tularaemia in Europe in humans, wildlife, 
domestic animals and vectors (paper I). 
 
➢ To describe the pathology in Swedish European brown and mountain hares 
and yellow-necked mice, with the purpose of learning more about possible 
routes of infection and shedding (paper II and III). 
 
➢ To elucidate the risk for humans and other animals to contract infection and 
to investigate possible sources of infection (paper I, II and IV). 
 
➢ To investigate the seroprevalence of F. tularensis in Swedish wild predators 
and scavengers, and to evaluate their suitability as biological indicators for 
occurrence, spread and/or increase of tularaemia prevalence (paper V). 
 
  
2 Aims of the thesis 
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3.1 Data collection (study I) 
In study I, information on tularaemia in Europe in humans, wild and domestic 
animals and vectors during a 20-year period was compiled. Data from 38 
European countries was retrieved and reported data and publications from 1992 
to 2012 were included. For humans and animals, the study was based on relevant 
databases and publications, while for vectors publications were the only source 
of data. 
3.1.1 Human data 
The database of the European Centre for Disease Prevention and Control 
(ECDC, 2014) was queried for data on reported human cases of tularaemia 
between 2006 and 2012, and the WHO-CISID database (World Health 
Organization, 2014) for 1992-2012. Case data by county/region and by year 
were also extracted from several National Public Health Institute websites. 
Population data produced by Eurostat (European Commission, 2014) was used 
for incidence calculations. A literature review was conducted in order to find 
additional case data and information on surveillance systems, type of clinical 
presentation, and source of infection and exposure, in order to assess the disease 
risk in humans. Information on type of study, event description, frequency of 
clinical forms, routes and sources of infection, exposures and/or identified risk 
factors was extracted. 
3 Materials and methods 
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3.1.2 Wild and domestic animal data 
Information about tularaemia and F. tularensis infection in wild and domestic 
animals was compiled from the World Organization for Animal Health (OIE) 
databases and from published articles. Because the OIE databases only included 
data from 1996 onward, data for the period from 1992 to 1995 was only available 
from published articles. The OIE databases used for this review were the World 
Animal Health Information Database Handistatus II (OIE Handistatus II, 2017) 
and the World Animal Health Information Database (OIE WAHIS, 2017). Data 
on the geographical range of tularaemia are available only as notification or no 
notification of tularaemia at the country level. Information on type of 
surveillance, outbreaks, disease status in wild and domestic animal species, 
estimated prevalence, source of infection, route of shedding and diagnostic 
methods used was extracted. 
3.1.3 Vector data 
For vectors, there are no official databases or obligations to report, information 
was solely extracted from studies investigating different types of arthropod 
species. For the purpose of this review, a vector was defined as any arthropod 
which can introduce F. tularensis into a susceptible host. Data extracted included 
arthropod species, country, number of arthropods sampled, number of 
arthropods for which the test gave a positive response, prevalence of F. 
tularensis in arthropods studied, and the diagnostic method used. All studies 
regarding arthropod vectors were of the type active surveillance. 
3.1.4 Mapping of data 
Maps were compiled to compare the reported distribution of F. tularensis in 
Europe in humans, wildlife, domestic animals, and arthropod vectors, and the 
different types of F. tularensis surveillance in humans across Europe. Due to 
restrictions in the resolution of the available data, all information is shown at the 
country level. Country base layers were downloaded from Global 
Administrative Areas (Global Administrative Areas, 2013), and maps were 
created in ArcGIS. 
3.2 Study animals 
All animals used in study II, III, IV and V were wild animals collected as part of 
the National Wildlife Disease Surveillance in Sweden. No experimental 
infections were conducted. 
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3.2.1 European brown and mountain hares 
In study II, all European brown hares (EBH) and Mountain hares (MH) 
necropsied 2000-2013 and diagnosed with tularaemia were investigated, in total 
49 EBHs and 37 MHs. From all, findings from the necropsies were compiled, 
but only 27 EBHs and three MHs had mild to moderate post-mortem changes 
and were suitable for histopathological and immunohistochemical examinations. 
In paper III, 32 EBHs and 10 MHs necropsied during the period 2007-2015, and 
one hunted EBH, were included. 
3.2.2 Yellow-necked mice 
Two yellow-necked mice (Apodemus flavicollis) found dead were necropsied 
and diagnosed with tularaemia (study III). 
3.2.3 Predators and scavengers 
Predator and scavenger species commonly found in Sweden were investigated 
in study V. Blood was sampled from all, tonsils and submandibular lymph nodes 
from a subset of the animals, details on animal species and samples are given in 
table 1. Sampling was performed in the period 2010-2015. 
Table 1. Number of animals of each species of predators and scavengers studied from which 
samples of blood and lymph nodes were obtained. 
Animal species Blood (no. of animals) Lymph node (no. of animals) 
Brown bear 50 50 
Eurasian lynx 34 33 
Raccoon dog 126 20 
Red fox 119 109 
Wild boar 248 27 
Wolf 59 59 
Wolverine 20 20 
Total no. of samples 656 318 
 
All brown brown bears (Ursus arctos), raccoon dogs (Nyctereutes procyonides) 
and wolverines (Gulo gulo) had died of trauma. Of the Eurasian lynx (Lynx lynx), 
red fox (Vulpes vulpes), wild boar (Sus scrofa) and wolf (Canis lupus), 9, 10, 7 
and 1% respectively, had died from disease or were euthanized due to disease. 
The remaining animals were hunted, killed in traffic or euthanized in restraining 
traps. 
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3.3 Laboratory diagnostics 
3.3.1 Histopathology and immunohistochemistry 
Histopathology and immunohistochemistry (IHC) were used in study II, III, IV 
and V. Pieces of tissue from internal organs (paper II, III and IV), muscles (paper 
III) and lymph nodes (study V) were fixed in 10% neutral buffered formalin, 
processed routinely, embedded in paraffin wax, sectioned at approximately 4 µm 
thickness, and stained with haematoxylin and eosin. Lesions were described and 
subjectively scored, based on their severity and extension, as negative, mild, 
moderate, marked or severe. In paper II, the area affected by necrosis was 
estimated as 0–20%, 20–50%, 50–75% or 75–100%. The abundance of each 
type of inflammatory cell (i.e. lymphocyte, plasma cell, heterophil and 
macrophage) was graded subjectively as not observed, few, moderate or 
numerous. IHC was applied on duplicate sections to visualize F. tularensis 
(study II, III, IV and V), and the presence of T-cells and B-cells (study II). The 
location of the labelled F. tularensis in paper II, III and IV was described as: 
present in lesions and/or in healthy tissue, present in blood vessels, intra- or 
extracellularly located, and in type of cells when located intracellularly. 
IHC for F. tularensis was performed on formalin-fixed tissues from all 
histopathologically examined organs using a mouse primary monoclonal 
antibody FB11 (Meridian Life Science Inc., Nordic Biosite AB, Täby, Sweden) 
directed against F. tularensis spp. lipopolysaccharide antigen. Sections were 
dewaxed and incubated with H2O2 in Tris-HCL, pH 7,6 for 15 min to block 
endogenous peroxidase activity.  Antigen was retrieved by proteinase K (Dako, 
Agilent, Glostrup, Denmark) treatment for 6 min; thereafter the sections were 
incubated at room temperature (RT) with 2% bovine serum albumin (BSA) 
(Sigma-Aldrich, Stockholm, Sweden) for 20 min to block non-specific labelling. 
The primary antibody was applied at a 1 in 3,500 dilution and the sections were 
incubated at RT for 45 min. Antibody binding was detected by use of the anti-
mouse EnVisionTM polymer detection system (Dako) and the sections were 
counterstained with Mayer’s haematoxylin. A serial section incubated with 2% 
BSA was used as negative control, and a known positive tularaemia sample from 
an EBH was used as positive control. Additionally, for some cases in paper II, a 
serial section was incubated with normal mouse serum and mouse IgG1 (Dako).  
This was also performed on sections known to be tularaemia negative. In paper 
III, where IHC was performed on yellow-necked mice, a modified method with 
an additional step using Vector®M.O.M™ (Vector Laboratories, Burlingame, 
CA) was applied to enable staining of F. tularensis with the mouse primary 
antibody FB11 in mouse tissue. Sections were incubated in the primary antibody 
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diluted in M.O.M Diluent at 1:3000 for 30 minutes, followed by incubation in a 
working solution of M.O.M. biotinylated Anti-Mouse Ig Reagent for 10 minutes. 
As detection system, the VECTASTAIN®elite ABC standard kit (Vector 
Laboratories, Burlingame, CA) was used. 
 
Immunohistochemistry for detection of T lymphocytes (mouse primary 
antibody CD3 monoclonal; Dako) and B lymphocytes (mouse primary antibody 
CD79; BioCare Medical, Pacheco, California, USA) was performed on selected 
cases and organs to identify cell types (study II).  Sections were dewaxed and 
antigen was retrieved in a microwave oven (in Tris EDTA buffer, pH 9.0) at 750 
W for 7 min followed by 350 W for 14 min. To block endogenous peroxidase 
activity, sections were incubated with H2O2 in Tris-HCL, pH 7,6 for 20 min; 
thereafter the sections were incubated at RT with 2% BSA for 20 min to block 
non-specific labelling. The primary antibody was applied at 1 in 75 (CD3) or 1 
in 30 (CD79) dilution and the samples were incubated at RT for 45 min. 
Antibody binding was detected by use of the anti-mouse EnVisionTM polymer 
detection system (Dako) and the sections were counterstained with Mayer’s 
haematoxylin.  A serial section incubated with 2% BSA was used as a negative 
for control. 
3.3.2 Immunofluorescence 
Indirect immunofluorescence (IIF) (study III) was performed on unstained 
formalin fixed tissue sections using an in-house Francisella tularensis-positive 
rabbit serum (polyclonal antibodies), (SVA, Uppsala, Sweden) for detection. 
Sections were incubated in a 37°C moist-chamber for 30 minutes with the rabbit 
primary polyclonal antibody diluted 1:20 in 0.05 M phosphate buffer, pH 7.9 
(PBS). After rinsing the slides in PBS, a secondary fluorescein-labelled goat 
anti-rabbit IgG (H+L) (Vector, Laboratories, Burlingame, CA) diluted 1:20 in 
PBS was applied. The slides were incubated in a 37°C moist-chamber for 30 
minutes. The slides were rinsed in PBS and mounted with a cover glass and 
phosphate-buffered glycerol, pH 8.6. To exclude false negative staining, a tissue 
section from a known tularaemia-positive sample was examined in the same 
way.  To exclude false positive staining, serum from a known tularaemia-
negative rabbit was used as primary antibody. The slides were examined in a 
fluorescence microscope, excitation 490 nm and emission 530 nm. A bright 
green fluorescence and a morphology consistent with the bacterium was 
considered as positive. 
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3.3.3 Slide agglutination and microagglutination 
To detect F. tularensis antibodies, slide agglutination and microagglutination 
were performed on all blood samples in study V.  
In the slide agglutination test, a F. tularensis antigen was used (Bioveta a.s., 
Ivanovice na Hané, Czech Republic). 40 µl of the sample was mixed with 200 
µl of the containing F. tularensis-containing solution and the result was read 
after 1-3 minutes. A positive result was assessed as presence of agglutination 
flakes and clarification of the surrounding solution. 
For the microagglutination, a protocol from Wageningen Bioveterinary 
Research (WBVR), Wageningen, the Netherlands was used. F. tularensis non-
viable bacteria in 0,5% formaldehyde with addition of crystal-violet (Becton 
Dickinson AB, Stockholm, Sweden) was used as antigen. The antigen was 
diluted in saline solution in the ratio 1:15 to create a working solution. Eighty 
microliters of antigen working solution was mixed with 20 μl of serum in the 
first row of a 96-well V-bottom microtiter plate (VWR International, Stockholm, 
Sweden). 50 µl of the mixture was transferred to the next row, containing 50 µl 
of the working solution. This procedure was repeated to the last row, causing a 
two-fold dilution in each step and the titres to be tested 1:5, 1:10, 1:20, 1:40, 
1:80, 1:160, 1:320 and 1:640. A known positive serum (Germaine Laboratories, 
San Antonio, United States), and a negative rabbit serum (Bio Jet Service, 
Uppsala, Sweden) was used as positive and negative controls for each plate. The 
plate  was sealed (VWR International, Stockholm, Sweden)  and  incubated  for 
 21 +/- 1 hour at 37°C. The wells were examined visually using a light box. 
3.3.4 Polymerase chain reaction (PCR) 
Real-time PCR to detect F. tularensis subsp. holarctica was used in study II-V. 
Tissues sampled were internal organs from hares (study II) and yellow-necked 
mice (study III), muscles from hares (study IV), and lymph nodes from predators 
and scavengers (study V). Material from the tissue samples was retrieved using 
sterile cotton swabs. The swabs were incubated in 380 μl G2 buffer and 20 μl 
proteinase K solution (study II, III and V) or 570 μl G2 buffer and 30 μl 
proteinase K solution (study IV). (EZ1 Tissue DNA Extraction Kit, Qiagen, 
Sollentuna, Sweden) at 56°C for 15 min under continuous agitation, followed by 
5 min incubation at 95°C. DNA was extracted from 200 μl of the resulting lysate 
using the EZ1 Tissue DNA Extraction Kit and the EZ1 Advanced Instrument 
(with the Bacteria Card) (Qiagen). The DNA was eluted in 50 μl elution buffer 
and 1 μl was used as template for each PCR (study II, III and V), or in 100 μl 
elution buffer and with 2 μl used as template (study IV). In study II, Francisella 
tularensis subsp. holarctica genotyping was performed in 23 hares for typing of 
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the three major canSNP-groups B.4, B.6 and B.12, and the subgroups B.7, B.10, 
B.20, B.23 and B.39 (Karlsson et al., 2013, Svensson et al., 2009;) according to 
the qPCR-based method described previously (Karlsson et al., 2013). 
3.3.5 Bacteriological culture 
In study IV, 14 muscle samples were analysed by aerobic bacterial culture to 
investigate if F. tularensis were able to grow after variable length of storage in 
a freezer at -20°C. The samples had been stored for approximately 0.5 (one 
sample), 1 (two samples), 2 (two samples), 3 (two samples), 4 (three samples), 
5 (two samples), 7 (one sample) or 8 years (one sample). The samples were 
cultured on T4 medium as described previously in Harmonization of methods at 
BSL-3 laboratories (Thelaus et al., 2012). T4 medium contains 37 g/L brain-
heart infusion (Oxoid, Hampshire, UK), 15 g/L Bacto-agar (Neogen, 
Auchincruive, UK), 10 g/L sodium chloride (Honeywell, Morris Plains, NJ), 90 
mL/L sheep blood (Håtunalab, Bro, Sweden), 1 g/L L-cysteine, 10 g/L glucose, 
2.7 mg/L amphotericin B, 5 mg/L vancomycin, 2.5 mg/L trimethoprim and 2.8 
mg/L cefsulodin (Sigma-Aldrich, St-Louis, MO) making it selective for 
Francisella. The culture plates were incubated at 37ºC for four days and checked 
for growth daily. 
In study II, aerobic general bacterial culture was performed on selected organ 
samples (seven lungs, two kidneys, nine livers, three spleens, one uterus and two 
testicles) from 13 tularaemic hares suspected to be co-infected with additional 
bacteria. A few samples were submitted for culture in conjunction with the 
necropsy examination, while the rest had been stored at –20°C for up to 7 years. 
The samples were transferred to horse blood agar (in house) and a purple agar 
plate (in house). Plastic loops were changed between primary, secondary and 
tertiary streaks. The plates were incubated in an aerobic atmosphere at 37°C and 
analyzed after 1 and 2 days. 
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4.1 Tularaemia in Europe 
In study I, information was retrieved from databases and publications for the 
period 1992-2012, aiming to compile the information on tularaemia in Europe 
in humans, wild and domestic animals, and vectors during the recent two 
decades. The level of reporting for humans and animals differs between 
countries leading to gaps in the retrieved information, but it can be concluded 
that tularaemia is widely distributed in Europe. In humans, an overall seasonal 
pattern with most cases occurring during summer and early autumn was seen. 
However, at country level the seasonality varied with peaks in spring, summer, 
summer/autumn and winter. In European wildlife in our study I, a seasonality 
pattern was not obvious, but other studies describe outbreaks associated with the 
mosquito season in hares in Scandinavia (Josefsen et al., 2012; Morner et al., 
1988; Vikoren and Djonne, 2008; Vikoren et al., 2008). In study I, published 
information regarding bacterial detection and serology in wild and domestic 
animals was reviewed for the chosen time period. In wildlife, F. tularensis was 
detected in hares, rabbits, several small rodent species and birds. Antibodies 
against F. tularensis was reported in hares, red fox and wild boar. Fewer studies 
investigated domestic animals, but antibodies have been reported in ruminants, 
dogs and cats. Studies on vectors mostly concern ticks and mosquitos, and we 
found that the bacterium has been detected in several species. Tularaemia occurs 
with outbreaks in both endemic and new geographic areas. Different 
geographical areas have different ecosystems, which influence the epidemiology 
and disease presentation. Such factors include temperature and humidity, the 
presence of different kinds of arthropod vectors, and the variety of wildlife 
species present. There are highly endemic areas, or natural foci, where cases 
occur most years and in higher numbers compared to other endemic areas 
4 Results and discussion 
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(Gurycova et al., 2001; Olsufjev, 1963; Tarnvik et al., 1996). The differences in 
the level of reporting of tularaemia, type and level of surveillance, and presence 
of different hosts and vectors, makes it difficult to make direct comparisons 
across all of Europe. Understanding of the disease epidemiology would benefit 
from coordination between countries, for example for level of reporting and type 
of surveillance. 
4.2 Wildlife 
4.2.1 Pathology 
European brown hares and mountain hares 
Tularaemia is often considered to be acute in MH (Josefsen et al., 2012; Morner 
et al., 1988; Vikoren and Djonne, 2008; Vikoren et al., 2008), and 
subacute/chronic or acute in EBHs (Decors et al., 2011; Gyuranecz et al., 
2010b). However, it should be noted that in the studies reporting 
subacute/chronic lesions in EBH the hares had been hunted, thus were 
apparently (clinically) healthy. Conversely, the reports of acute forms of disease 
in EBH as well as in MH were conducted on animals that had been found dead 
or moribund. In the former disease presentation (subacute/chronic) the animals 
had seemingly survived the acute phase of disease while in the latter (acute or 
per-acute) tularaemia was fulminant. One could assume that a hare that has a 
longer course of disease would be in a poorer nutritional state, losing weight 
during the course of the infection, when compared to hares that die from acute 
disease. In study II, the pathology of EBH and MH found dead or moribund was 
described. When comparing the nutritional state in EBH and MH, no statistically 
significant difference between the two hare species could be found. Organ 
enlargement and grossly visible necroses were frequently found in the spleen, 
bone marrow and liver in both hare species, but lung lesions were found only in 
the EBH. There was a statistically significant difference in the presence of 
grossly visible necroses between MH and EBH in the bone marrow (41% in MH, 
12% in EBH), and in the lung (none in MH, 14% in EBH). In general, gross 
lesions were present in a higher number of organs in each individual in the EBH 
than in the MH. In 30% of the hares no or minimal grossly visible lesions were 
seen. The histopathology could not be statistically compared between species 
since only three MH, but 27 EBH, were suitable for examination. Acute lesions 
were present in both species, and necroses were visible in liver, spleen, bone 
marrow, lymph nodes and adrenal glands in the majority of the hares, most often 
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with an associated mild inflammation consisting of macrophages, lymphocytes 
and plasma cells, and lesser numbers of heterophils (Fig 1a).   
 
Figure 1. Liver. Acute changes showing necrotic foci in HE (A), and immunohisto-
chemical staining of intralesional F. tularensis (B). 
 
Many other organs, investigated in fewer animals, were also involved, such as 
gonads, lactating mammary glands, heart and intestine. Several of the EBHs had 
meningitis with occasional adjacent encephalitis, and pneumonia. Encephalitis 
has also been described in a Japanese hare (Lepus brachyurus augustidens) 
found dead (Park et al., 2009). In study II, more severe and chronic lesions were 
seen in the lungs of five EBH and the kidneys of three EBH (Fig 2a). 
 
Figure 2. Chronic lesion in the lung. Necrosis with severe inflammation destroying the 
tissue, HE (A). Immunochemical staining showing F. tularensis (B). 
 
Lesions of this type have also been described in hunted EBH in Germany and 
Hungary (Gyuranecz et al., 2010b; Sterba and Krul, 1985). In our study II, dual 
infection by Klebsiella pneumoniae and F. tularensis was confirmed in the lungs 
of one hare. One other hare presented with dual infection Escherichia coli and 
F. tularensis infection in the kidney, but in the remaining hares with suspected 
dual infections the results were inconclusive. Dual infection with K. pneumoniae 
has previously been described in man (Givham, 1965).  Immunohistochemistry 
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(IHC) for F. tularensis in our hares detected the bacterium extra- and 
intracellularly in association with necrosis and inflammation, with the most 
common intracellular location being in macrophages (Fig 1b, 2b). This finding, 
together with the dissemination of F. tularensis in many organs, show that the 
hares died of an acute disseminated disease, which is in accordance with the 
pathology in EBH found dead in France (Decors et al., 2011) and in MH found 
dead in Sweden and Norway (Josefsen et al., 2012; Morner et al., 1988; Vikoren 
and Djonne, 2008; Vikoren et al., 2008). In conclusion, since the hares in our 
study were all found dead or moribund, this increased the likelihood of finding 
acute lesions of tularaemia, that actually caused the death of the animals. 
Including hunted healthy hares in the study, would have increased the chances 
of finding more chronic lesions. Further research is warranted to characterize the 
range of pathological presentations since this will help to elucidate if the EBH 
may serve as reservoir for F. tularensis subsp. holarctica also in Sweden. The 
presence of chronically infected hares may also increase the risk of exposure to 
hunters and hunting dogs, since the hares may be apparently healthy, particularly 
since gross pathological lesions were absent in 30% of infected hares. 
Yellow-necked mice 
In study III, the pathology in two yellow-necked mice is described. The only 
gross lesion was an enlarged spleen in one mouse. By histopathology, both mice 
had necroses and associated mild inflammation. Due to marked post-mortem 
changes the remaining organs were difficult to assess, but there was a strong 
suspicion of necroses in both mice´s spleen and lung. To detect and visualize the 
bacteria, real-time PCR, IHC and indirect immunofluorescence (IIF) was used. 
F. tularensis was detected in the liver, spleen, bone marrow, lung and kidney 
(Fig. 3).  
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Figure 3. Immunohistochemistry for F. tularensis reveals bacterial presence in the 
cytoplasm of pneumocytes (orange arrow) and alveolar macrophages (black arrow). 
 
Bacteria were found in necroses and blood vessels, and intracellularly in 
macrophages and pneumocytes. The pathological findings in the yellow-necked 
mice were similar to those described in laboratory mice (Conlan et al., 2003), 
wild common hamsters (Cricetus cricetus) (Gyuranecz et al., 2010a) and 
laboratory-born field voles (Microtus agrestis) and bank voles (Myodes 
glareolus) experimentally infected with F. tularensis subsp. holarctica (Rossow 
et al., 2014). In naturally infected field voles in Finland and free-ranging house 
mice in Switzerland, necrosis in spleen, liver and/or lung were found (Origgi et 
al., 2015; Rossow et al., 2014).  
The role of small rodents in the epidemiology of tularaemia in Sweden has 
not been thoroughly investigated. Wildlife disease surveillance is mainly passive 
and small rodents are seldom submitted for investigation. Among the few 
rodents investigated at SVA during the last decade, tularaemia has only been 
diagnosed in the two yellow-necked mice in study III, and in a few lemmings 
(unpublished data). More information about the disease in small rodents is 
necessary to better understand their role in the epidemiology. In the literature it 
is frequently discussed whether small rodent species die of acute disease or if 
they may survive and act as reservoirs or transmitters of the bacteria. There is a 
high diversity among the rodent species, and the sensitivity to develop disease 
differs among them.  
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Hare meat 
Examination of muscle samples from 43 tularaemic EBH and MH with general 
tularaemic lesions as described in study II, showed that F. tularensis may also 
infect muscle tissue (study IV). The meat may contain F. tularensis, either due 
to transportation via the blood stream during the disease process (sepsis), or due 
to post-mortal contamination from infected internal organs. F. tularensis was 
detected by PCR and/or IHC in 40 of the 43 hares. The most common location 
was in the connective tissue of the perimysium surrounding medium-sized 
arteries. F. tularensis was frequently seen intracytoplasmic in macrophages, but 
also in the cytoplasm of fibroblasts and lymphocytes, or extracellulary. In the 
endomysium the bacteria were mostly intracytoplasmic in spindle cells, 
presumably fibroblasts (Fig. 4a). In three of the samples F. tularensis was 
detected intravascularly (Fig. 4b).  
 
 
Figure 4. Immunhistochemistry for F. tularensis. F. tularensis located in the cytoplasm 
of a spindle cell (A), and in high numbers intravascularly (B). 
 
By routine histopathology the only signs of infection in the muscle tissue 
were mild infiltration of macrophages and a few lymphocytes and plasma cells, 
mostly associated with the presence of F. tularensis shown by IHC. In two 
samples, small areas of necrosis were evident in the perimysium with mild 
infiltration of macrophages and lymphocytes. Bacterial culture for F. tularensis 
was positive in two out of 14 cultured samples, both stored in -20°C for 
approximately one year. This is in accordance with a Russian study where sheep 
were experimentally infected with F. tularensis and the meat still contained 
viable bacteria after storage at -20°C for 60-75 days (Airapetyan and 
Khachatryan, 1956). Our findings in study IV, show that even if hunters and 
others who handle the hares are very careful not to contaminate the meat, there 
is still a risk to contract infection when ingesting under-cooked meat since F. 
tularensis may infect the muscles during the disease process. The risk is 
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accentuated by the findings in study II, that showed that 30% of the hares did 
not have visible gross changes in their organs. 
4.2.2 F. tularensis subsp. holarctica genotypes 
In study II, F. tularensis subsp. holarctica genotypes were investigated in 
samples from 23 hares to see if any pathological differences were associated 
with infection by different genotypes. Two genotypes, B.6 (subgroup B.7), and 
B.12 (subgroups B.20, B.23 and B.39), were found but pathological presentation 
did not differ between them. This is in contrast with findings in tularaemic EBHs 
in Switzerland where two canSNP groups, B.6 (subgroup B.10) and B.12 
(subgroup B.13) were found to have different disease presentations (Origgi and 
Pilo, 2016). The authors concluded that canSNP group B.6 (subgroup B.10) was 
associated with splenitis and hepatitis, while canSNP group B.12 (subgroup 
B.13) was associated with lesions in the pleura, pericardium and kidney, as 
described in Hungary (Gyuranecz et al., 2010b; Origgi and Pilo, 2016). The 
majority of the hares in our study presented with lesions in the spleen, liver and 
many other organs, regardless of which of the two canSNP groups the strains 
belonged to. Hares with a more severe and chronic disease presentation could be 
found in both canSNP groups. Since the subgroups found for each canSNP group 
differed between our study II and the studies performed in Hungary (Gyuranecz 
et al., 2010b) and Switzerland (Origgi and Pilo, 2016), the possibility of a 
difference in disease presentation on that level cannot be excluded. 
4.2.3 Serology in wild predators and scavengers 
Many predator and scavenger species are considered to be relatively resistant to 
develop disease when infected by F. tularensis (Olsufjev, 1970 see Sjöstedt 
2007). As other animal species, they might get infected by vector-bites 
(mosquitos, ticks), by direct contact or through ingestion and inhalation. One 
further mean of infection is predation or scavenging on infected prey such as 
hares and small rodents. The predators and scavengers produce antibodies 
against F. tularensis upon infection, and might also harbour bacteria in their 
organs. European studies have shown that raccoon dogs, red foxes and wild boar 
may be useful as biological indicators for tularaemia (Hoflechner-Poltl et al., 
2000; Hubalek et al., 1993; Hubalek et al., 2002; Kuehn et al., 2013; Otto et al., 
2014). Antibodies have also been detected in Japanese black bears (Ursus 
thibetanus japonicas) and Japanese raccoon dogs (Nyctereutes procyonides 
viverrinus) (Sharma et al., 2014). In study V, an investigation of the Swedish 
predator or scavenger species brown bear, Eurasian lynx, raccoon dog, red fox, 
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wild boar, wolf and wolverine was performed. In total, 656 blood sera were 
investigated by slide agglutination and microagglutination. In the slide 
agglutination test, one brown bear and one wild boar were positive. In the 
microagglutination test, one brown bear (titer 1:80), one wolverine (titer 1:40), 
one red fox (titer 1:20) and nine wild boar (titers 1:20, 1:40 and 1:80 in six, two 
and one animals respectively) were positive. The slide agglutination test is a 
simple and quick method that can be used on whole blood. Since our study only 
managed to detect titers at 1:80 and above, our assessment is that this method is 
not suitable for these species since 10 animals positive in microagglutination, all 
with titers 1:20 or 1:40, were not detected by the slide agglutination test. On the 
other hand, the microagglutination method is more dependent of good quality 
sera and due to haemolysis 559 samples were readable at titer 1:20, and only 357 
samples at titer 1:10. Examples of testing of good and haemolytic sera 
respectively are seen in figure 5.  
 
 
Figure 5. Microagglutination for detection of F. tularensis antibodies. Presence of a 
blue dot indicates a negative titer. A shows the readability with good quality sera and, 
B with haemolytic sera (B). 
 
This indicates that the true number of positive animals is probably higher than 
what is shown in this study. This is exemplified by the fact that nine of the 
positives were hunted wild boar from which good quality sera were available. 
For seroprevalence studies it is important to apply a method that is sensitive 
enough to detect low antibody titers despite poor quality sera. In Sweden, larger 
hunting events only take place in the southern and central parts of the country. 
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In areas where tularaemia is more frequent, hunting is mostly executed by one 
or a few hunters and spread over the whole hunting season. Sampling 
opportunity is dependent on the voluntary participation of hunters taking and 
submitting the samples themselves, which often results in haemolysis during 
transportation of the blood sample. In our study, to elucidate if F. tularensis was 
present in lymphoid tissues in serological positive animals, tonsils and 
submandibular lymph nodes were investigated separately by real-time PCR and 
IHC. From the twelve positive animals, lymphoid tissues were available only 
from three, a brown bear, a red fox and a wolverine, and no bacteria could be 
detected. In a study conducted by Hofer et al. 2010, F. tularensis was found in 
the submandibular lymph nodes of red foxes (Hofer et al., 2010). An active 
serologic surveillance of indicator species on the borders surrounding endemic 
areas of tularaemia, could be a useful tool to enable early detection of spread of 
disease. 
4.3 Routes of infection and shedding 
The routes of infection of F. tularensis are through bites of vectors (frequently 
mosquitos and ticks), direct or indirect contact, ingestion of infected food or 
water, and inhalation of infected aerosols or dust. In Sweden, mosquitos are 
frequently linked to infection in humans (Ryden et al., 2012), and it could be 
assumed that this is true also for animals. One study found F. tularensis in 
several mosquito species (Lundstrom et al., 2011). Since the 1980´s there have 
been milder winters, which has allowed the ticks to expand further north in 
Sweden (Lindgren and Jaenson, 2006), presumably being an increasingly 
important source of infection for humans and animals. In central and southern 
Europe F. tularensis has been detected in several tick species, including Ixodes 
ricinus, the most common tick species in Sweden (study I). During the 
necropsies in study II, ticks were found still attached to the skin bite-lesion in 
two EBH, and IHC showed presence of F. tularensis in the skin lesion, proving 
it to be the route of infection (Fig 6).  
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Figure 6. Skin lesion at the site of a tick-bite, HE (A) and immunohistochemistry for  
F. tularensis (B). Necrosis and inflammation with numerous intralesional F. tularensis 
(*).  
 
This has also been described in a mountain hare (Morner et al., 1988) and a 
Japanese hare (Park et al., 2009). Wildlife, since living in the nature, could be 
more prone to acquire infection through contaminated soil and water. 
Contamination may be from live or dead tularaemic animals, urine, faeces, blood 
and other secretions from infected animals (Larssen et al., 2011). There are also 
studies showing the presence of the bacterium in water and sediment, these 
elements being possible reservoirs in the environment (Broman et al., 2011). In 
study II, several routes of shedding were described based on the pathology and 
associated IHC-labelling. By IHC, F. tularensis, were detected in exudate in the 
milk of lactating mammary glands, in exudate in airways and in exudate in the 
renal pelvis (Fig 7).  
 
41 
 
Figure 7. Renal pelvis to the left, and an inflammatory exudate in the pelvic lumen to 
the right containing numerous F. tularensis bacteria, shown by immunohistochemistry. 
 
F. tularensis were also found in superficial mucosal lesions in the uterus and 
intestine of a few hares. However, most of the investigated hares did not have 
any of these lesions, and they presumably died of sepsis before lesions in these 
organs had time to develop. Hares presenting with chronic lesions, for example 
in the lungs and kidney, might be more common than we are aware of. If so, 
these hares could be of importance for the epidemiology of tularaemia, e.g, 
serving as shedders and reservoirs of F. tularensis. In hunted EBH in Hungary, 
chronic lesions in the kidney and lung were common, and EBH is considered to 
be a reservoir species (Gyuranecz et al., 2010b). Small rodents are often 
implicated as sources of infection and/or reservoirs. Carcasses of infected 
animals, like the yellow-necked mice in study III, may contaminate the 
environment, e.g. water wells (Larssen et al., 2011). If the rodent species are 
more resistant to develop fulminant disease, such as rats (Rattus spp.) (Sjöstedt 
2007), bacteria may be shed and contaminate the environment through their 
faeces and urine (Larssen et al., 2011; Reintjes et al., 2002). 
4.4 Risk factors 
Common risk factors for humans are consumption of contaminated water and 
food, direct contact with infected wildlife, arthropod bites and exposure to 
infected environments via air (study I). This means that hunters, farmers and 
people taking part in outdoor activities are at greater risk to contract infection. 
In study II, 30% of the 86 investigated hares had no or minimal visible lesions. 
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Hunters dressing hunted hares may not notice that the hare is diseased, and if 
they do not use protective gloves they are at risk to get infected through skin 
contact. As shown in study IV, bacteria may also be found in the meat. If internal 
organs, for example the liver, or the meat are undercooked there is a risk to get 
infected through ingestion. In Sweden, there are no reports of people contracting 
tularaemia after consumption of hare meat, but there are reports from France and 
the Netherlands (Benlyazid et al., 1997; Maurin et al., 2011; Warris-Versteegen 
and van Vliet, 2003). Likewise, hunting dogs fed uncooked morsels may 
contract infection. Another example is a Norwegian hunting dog that was 
infected after killing a diseased mountain hare (Nordstoga et al., 2014). Infected 
small rodents may contaminate food, water and dust such as hay on a farm, 
causing infection in humans and animals. In Kosovo, human tularaemia cases 
were connected to small rodents in food storage, and in Norway lemmings 
contaminated private water wells (Larssen et al., 2011; Reintjes et al., 2002). 
More seldom, infection through inhalation occurs. During outbreaks in Sweden 
1966-1967, and in Finland 1982, hay dust was implicated as the source for 140 
and 53 diseased humans respectively (Syrjala et al., 1985; Tarnvik and 
Berglund, 2003). Further investigations, including pathology, of different 
wildlife species such as hares and small rodents would help to elucidate and 
further understand different risk factors, and to evaluate their importance. 
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Tularaemia involves animal health, human health and the environment and it is 
therefore best approached from a One Health perspective. This thesis has 
focused on a review of the epidemiology, pathology of key species, and serology 
studies of F. tularensis infection. The aim of the studies was to contribute to the 
understanding of the epidemiology of this complex zoonotic disease. In 
summary: 
 
➢ Tularaemia is widely distributed throughout most of Europe and has 
repeatedly shown signs of local emergence and re-emergence in humans and 
wildlife. There are considerable differences in surveillance and reporting 
between countries. Additionally, there are geographical and regional 
differences connected to ecosystems, the presence of different species of 
arthropod vectors, and the variety of small rodent and other wildlife species 
involved. Therefore, it is difficult to make direct comparisons across all of 
Europe. 
 
➢ The pathology of tularaemia was similar in Swedish European brown hares 
and mountain hares, both presenting with acute disseminated disease in most 
individuals. One important difference between the two hare species was the 
finding of more severe and chronic lesions in the lung and kidney in a few of 
the European brown hares.  
 
➢ The pathology of two necropsied yellow-necked mice showed acute lesions 
and disseminated disease.  
 
➢ Routes of shedding from infected hares that might be of importance are, in 
addition to biting insects, via urine, milk, uterine secretions and intestinal 
content, and dead animals. The finding that some European brown hares had 
5 Conclusions 
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chronic lesions indicate that these hares may shed F. tularensis for longer 
times than previous recognized. 
 
➢ The finding of chronic lesions in some of the European brown hares raises 
the question of hares being a possible reservoir of F. tularensis in Sweden. 
 
➢ The findings of chronic disease in some European brown hares, the absence 
of readily visible pathological changes in up to 30% of the hares and the 
finding of F. tularensis in the muscle of hares shows that hunted hares and 
particularly under-cooked hare meat, could be a risk factor for contracting 
tularaemia. 
 
➢ Active surveillance in combination with passive surveillance of small rodent 
species is needed to characterize tularaemia in these species in order to better 
understand the role of rodents in the epidemiology of F. tularensis infection. 
 
➢ Active serologic surveillance of indicator species in areas surrounding 
endemic areas of tularaemia could enable early detection of spread of disease. 
In endemic areas, a variation in seroprevalence between years will contribute 
to the knowledge of disease dynamics.  
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Since tularaemia is a complex disease involving man, many different species of 
animals and arthropod vectors, the knowledge and understanding of its 
epidemiology would benefit from studies involving several aspects 
simultaneously. One part of this would be active surveillance of indicator 
species, animal species that survive infection since they are less susceptible to 
develop disease. To make this possible, simple and robust field-based diagnostic 
methods, applicable to multiple animal species, are needed. There are limited 
existing data on the pathobiology of the infection in different small rodent 
species. The knowledge gaps of natural infection in small rodents include the 
range and variability in pathological presentation, and the distribution and 
abundance of bacteria in organs and excretions. Pathological investigations of 
different species of naturally infected small rodents would contribute to the 
understanding of the different species´ roles as potential transmitter or carriers 
of the infection. The present findings of lesions of a chronic type in some 
diseased European brown hares in Sweden, together with findings of chronically 
infected hares in for example Hungary and Germany, warrant further 
investigations of this hare species and its potential role as a reservoir of 
tularaemia in Sweden. 
6 Future perspectives 
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Tularaemia is a vector-borne disease caused by the bacterium Francisella 
tularensis. Tularaemia is a zoonotic disease, meaning that it may cause disease 
in both humans and animals. F. tularensis may infect a wide range of hosts 
including mammals, birds and arthropods such as ticks and mosquitos. There are 
several subspecies of the bacterium but only F. tularensis subsp. holarctica 
causes significant disease in humans and animals in Europe. The susceptibility 
of various hosts to develop disease is variable. For example, certain lagomorphs 
as mountain hares and many small rodent species succumb to fulminate disease, 
while many species of carnivores and omnivores, e.g. red fox and wild boar, 
show no or mild signs of disease upon infection. Tularaemia is a complex disease 
involving many different animal species, but also vectors such as ticks and 
mosquitos, and the environment. Knowledge is lacking regarding possible 
reservoirs for F. tularensis, where the bacterium may survive and be a source of 
infection. There are theories that possible bacterial reservoirs could be water 
courses, ticks and certain animal species. F. tularensis has several infection 
routes, e.g. skin, respiratory organs and pharynx. The bacterium may be shed 
from diseased individuals, for example through urine and faeces, and dead 
infected animals can infect the environment. 
This thesis reviewed the literature for the time-period 1992-2012 regarding 
the presence of tularaemia in humans, wild and domestic animals, and vectors 
such as ticks and mosquitos, in Europe. Through autopsies and microscopic 
investigations (pathology) of European brown hares, mountain hares and 
yellow-necked mice, organ lesions caused by the disease were investigated. The 
presence of antibodies against F. tularensis (serology), produced by the infected 
individuals immune defence, was investigated in selected Swedish predator 
and/or scavenger species. 
Tularaemia is widely distributed throughout most of Europe. Differences in 
surveillance and reporting of the disease, different ecosystems, the presence of 
different kinds of arthropod vectors (e.g. ticks and mosquitos), and the variety 
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of small rodent species and other wildlife species make direct comparisons 
across all of Europe difficult. 
The pathology of tularaemia in European brown hares, mountain hares and 
two yellow-necked mice was similar. The infection involved many organs and 
had a short course that rapidly caused death of the animals. However, some of 
the European brown hares, in addition to the acute lesions, also had chronic 
changes in the lungs and/or kidneys. This shows that these hares had been sick 
for a longer period of time before the disease fulminated, and raises the question 
if the European brown hare in Sweden could function as a bacterial reservoir, as 
described elsewhere in Europe. F. tularensis infection was demonstrated in 
muscles of infected hares, which highlights the risk of acquiring infection 
through consumption of under-cooked meat. 
Many predators and omnivores do not develop disease after infection but may 
develop antibodies, thus serological investigations show if they are, or have 
been, infected with F. tularensis. In wildlife disease surveillance, this could 
inform on whether tularaemia is spreading to new areas, and if there are seasonal 
or annual variations in areas where tularaemia is endemic, i.e. where it is always 
present. In our study, antibodies towards F. tularensis were detected in the 
brown bear, red fox, wild boar and wolverine. 
The results of our studies contribute to the current knowledge of tularaemia 
in Europe, its pathology in European brown hares and yellow-necked mice, and 
its possible routes of infection and shedding. Additionally, it contributes to the 
understanding of the role of predators and scavengers in the epidemiology of 
tularaemia. The results of our studies highlight the importance of further 
investigations of different wildlife species to explore their role in the 
epidemiology of tularaemia, as possible sources of infection, transmitters of 
disease and potential reservoirs. 
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Harpest (tularemi) är en viktig zoonotisk sjukdom, vilket innebär att den kan 
infektera och överföras mellan ett stort antal djurslag, varav människa är ett. 
Harpest orsakas av bakterien Francisella tularensis, och i Europa är det 
underarten F. tularensis subsp. holarctica som orsakar sjukdom hos människor 
och djur. Känsligheten för att bli sjuk efter infektion varierar mellan olika 
djurslag. Som exempel kan nämnas att skogsharar och ett flertal smågnagararter 
är mycket känsliga och ofta drabbas av akut sjukdom som snabbt leder till döden, 
medan många kött- och allätare, t.ex. brunbjörn, järv, räv och vildsvin, inte 
insjuknar alls eller drabbas av mild sjukdom. Människors känslighet ligger 
däremellan. Om infektionen sker genom huden så uppkommer ett sår, och de 
lymfkörtlar som dränerar infektionsområdet svullnar. Detta åtföljs av 
influensaliknande symptom med feber. Harpest är en komplex sjukdom som 
involverar ett stort antal värddjur, men även vektorer såsom fästingar och 
myggor, samt omgivande natur. Mycket kunskap saknas om möjliga 
bakteriereservoarer, d.v.s. källor där bakterien kan överleva och varifrån den kan 
spridas vidare. Teorier finns om att möjliga reservoarer för bakterien kan vara 
vattendrag, fästingar och vissa djurarter. Infektion med F. tularensis kan erhållas 
via flera vägar, t.ex. hud, luftvägar eller svalg. Bakterien kan utsöndras från 
sjuka individer via t.ex. urin och avföring, och infekterade döda djur kan 
kontaminera den omgivande naturen. 
I denna avhandling har vi genom litteraturstudier undersökt förekomsten av 
harpest hos människa, vilda och tama djur, och vektorer i Europa under åren 
1992-2012. Undersökningar av vilka förändringar harpesten orsakar i kroppens 
organ (patologi) hos harar och större skogsmöss, samt förekomsten av 
antikroppar som kroppens immunförsvar bildat mot bakterien (serologi) hos 
vilda rovdjur och asätare har också utförts. 
Harpest förekommer i flertalet av Europas länder. Olikheter i 
sjukdomsövervakning och rapporteringsplikt, ekosystemens variation, 
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förekomst av olika vektorarter och arter av vilda djur gör det svårt att göra 
direkta jämförelser mellan länderna. 
I våra undersökningar var de förändringar som harpesten orsakade, likartade 
hos fältharar, skogsharar och två undersökta större skogsmöss. Infektionen hade 
ett snabbt förlopp med spridning till många organ och en snabbt inträdande död. 
Några av de undersökta fälthararna hade utöver de akuta förändringarna, 
kroniska förändringar i lungor och/eller njurar. Detta tyder på att de varit sjuka 
en längre tid innan sjukdomen akutiserades och ledde till döden. Detta väcker 
frågan om fältharar kan vara en reservoar för F. tularensis i Sverige, något som 
beskrivits i andra delar av Europa. Vid undersökningar av harmuskulatur 
konstaterades att bakterien även infekterade detta organ. Därmed finns det en 
risk att infekteras om man äter otillräckligt tillagat harkött. 
Många arter av rovdjur och asätare verkar inte bli sjuka när de infekteras. 
Eftersom de vid infektion kan bilda antikroppar som svar på bakterieinfektionen 
kan serologiska undersökningar av dessa djurarter ge svar på om de är eller har 
varit infekterade med F. tularensis. I övervakningen av viltsjukdomar kan 
resultaten ge svar på om harpesten är på väg att sprida sig till ett nytt område, 
och det ger också möjlighet att ta reda på hur förekomsten av harpesten varierar 
över tid. I vår studie fanns individer som bildat antikroppar mot F. tularensis hos 
brunbjörn, järv, rödräv och vildsvin. 
Resultaten av våra studier bidrar med kunskap om harpest i Europa, 
sjukdomsbilden hos fältharar och större skogsmöss, samt möjliga infektions- och 
utsöndringsvägar. Resultaten bidrar också till förståelse för att rovdjur och 
asätare kan ha betydelse för spridning av F. tularensis. Vidare undersökningar 
av olika vilda djurslag är viktiga för att se vad de har för betydelse i harpestens 
epidemiologi, för att ta reda på mer om möjliga infektionskällor, samt för att lära 
mer om vilka djurslag som kan tjänstgöra som smittspridare och potentiella 
reservoarer. 
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